On Thursday, Shares of eBay Inc. (NASDAQ:EBAY), gained 2.36% to $61.85.
eBay Inc., declared “Hot Deals for Hot Days,” a new experience that gives shoppers amazing deals on must-have items tied to the weather: the hotter the temperatures, the hotter the deals. Starting the Fourth of July, eBay will offer designer sunglasses at a deep discount that mirrors the forecasted high temperature of the day – if forecasted to be 85 degrees in Montauk, shoppers will get 85 percent off their new sunglasses.
Timed to summer’s biggest holiday, shoppers are invited to visit eBay’s “Hot Deals for Hot Days” custom Airstream to browse and buy new Ray-Bans and Michael Kors sunglasses, while cooling down with iced treats from Brooklyn’s People’s Pops. The eBay Deals Airstream will make its debut in the Hamptons on July 4th and then travel to New York City on July 7 and 8.
“If you’re looking for great deals on summer essentials, now is the time to shop eBay,” said style expert Kate Dimmock. “I check the eBay Deals site as often as I check my weather app, because each day there are new ‘it’ items for unbeatable prices.”
eBay Inc. operates as a technology company that enables commerce and payments on behalf of users, merchants, retailers, and brands of various sizes in the United States and internationally. It operates in three segments: Marketplaces, Payments, and Enterprise.
Shares of Voya Financial, Inc. (NYSE:VOYA), declined -0.63% to $46.97, during its last trading session.
Voya Financial, declared that it has designated David Wilken as president of the company’s Individual Life business, effective right away. In this role, Wilken will be responsible for the implementation and execution of a refined vision and strategy for the business, which supports Voya’s broader focus on assisting customers as they plan, invest and protect their savings for retirement. He will have overall responsibility for the strategy of the Individual Life business, and will directly manage product teams, distribution and sales, business development and underwriting. He will also join Voya’s Operating Committee. Wilken reports directly to Insurance Solutions Chief Executive Officer Michael Smith, who oversees the Individual Life, Employee Benefits and Closed Block Variable Annuity segments.
“With nearly 30 years of finance and sales leadership experience for Voya and its legacy companies, Dave has a true passion for life insurance and how it can assist customers grow, protect and enjoy their retirement savings,” said Smith. “Dave has been instrumental in our journey as Voya and has assisted our Individual Life business adapt to a dynamically changing market. His strong industry and institutional knowledge, together with a deep understanding of consumers and distributor needs, makes Dave the ideal candidate to lead the business as we advance Voya’s vision to be America’s Retirement Company.”
Voya Financial, Inc. operates as a retirement, investment, and insurance company in the United States. The company has five segments: Retirement, Annuities, Investment Administration, Individual Life, and Employee Benefits.
Finally, Agenus Inc. (NASDAQ:AGEN), ended its last trade with -1.94% loss, and closed at $8.61.
Agenus Inc., declared the appointment of C. Evan Ballantyne as the Company’s Chief Financial Officer, effective right away. Mr. Ballantyne will be responsible for all aspects of the Company’s financial, accounting, investor relations and corporate communication functions.
“We are happy to welcome Evan as our Chief Financial Officer,” said Garo H. Armen, Ph.D., Chairman and CEO of Agenus. “Evan has had a distinguished career, and we look forward to his contributions to the continued growth of our company.”
“This is a very exciting time for Agenus, and I look forward to working with the administration team as the company continues to advance its immuno-oncology platform technologies and product candidate pipeline and further develop its partnership opportunities,” stated Mr. Ballantyne.
Agenus Inc., an immunotherapy company, engages in discovering and developing innovative treatments for patients with cancer and other diseases. Its treatments focus on providing therapeutic benefit through modulation of immune function.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
